Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-17

Clinical Trial Update: Safety and Feasibility of Minocycline in the Treatment of Traumatic Brain Injury (TBI) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates safety and feasibility of minocycline for traumatic brain injury across Phase 1 and Phase 2; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Wayne State University | Conditions: Traumatic Brain Injury | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-09-17